Jasper Therapeutics Inc. (JSPR) is priced at $1.79 after the most recent trading session. At the very opening of the session, the stock price was $1.92 and reached a high price of $2.04, prior to closing the session it reached the value of $1.93. The stock touched a low price of $1.76.Recently in News on January 13, 2023, Jasper Therapeutics Announces New Positive Briquilimab Data to be Presented at the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR. Three abstracts highlight the safety and efficacy of briquilimab combined with low-toxicity radiation conditioning to achieve full donor engraftment and leukemia disease eradication. You can read further details here
Jasper Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.8000 on 01/03/23, with the lowest value was $1.3700 for the same time period, recorded on 01/06/23.
Jasper Therapeutics Inc. (JSPR) full year performance was -63.17%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Jasper Therapeutics Inc. shares are logging -69.19% during the 52-week period from high price, and 363.49% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.39 and $5.81.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 732736 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Jasper Therapeutics Inc. (JSPR) recorded performance in the market was 270.68%, having the revenues showcasing 141.89% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 64.08M, as it employees total of 25 workers.
Specialists analysis on Jasper Therapeutics Inc. (JSPR)
During the last month, 0 analysts gave the Jasper Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.9925, with a change in the price was noted -0.17. In a similar fashion, Jasper Therapeutics Inc. posted a movement of -8.67% for the period of last 100 days, recording 1,849,550 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for JSPR is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: Jasper Therapeutics Inc. (JSPR)
Raw Stochastic average of Jasper Therapeutics Inc. in the period of last 50 days is set at 41.12%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 40.65%. In the last 20 days, the company’s Stochastic %K was 42.48% and its Stochastic %D was recorded 42.37%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 270.68%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -12.68%, alongside a downfall of -63.17% for the period of the last 12 months. The shares increased approximately by 0.56% in the 7-day charts and went down by 244.23% in the period of the last 30 days. Common stock shares were driven by 141.89% during last recorded quarter.